Bharat Immunologicals & Biologicals Corporation Ltd. benchmarking: Perfomance to industry peers

Financial

	Bharat Immunological	JFL Life Sciences	Vivimed Labs
Operational Metrics
Financials
5 yr Average ROE	0.0	12.26 %	184.61 %
5yr average Equity Multiplier	3.08	2.68	-33.72
5yr Average Asset Turnover Ratio	0.61	0.93	0.27
5yr Avg Net Profit Margin	-18.38 %	5.75 %	-54.08 %
Price to Book	0.91	1.56	0.0
P/E	0.0	13.61	0.0
5yr Avg Cash Conversion Cycle	206.63 Days	138.58 Days	184.52 Days
Inventory Days	125.06 Days	96.42 Days	244.76 Days
Days Receivable	61.4 Days	135.23 Days	246.32 Days
Days Payable	117.81 Days	103.44 Days	159.64 Days
5yr Average Interest Coverage Ratio	-2.32	4.03	-6.61
5yr Avg ROCE	-44.64 %	17.72 %	-13.87 %
5yr Avg Operating Profit Margin	-18.7 %	10.31 %	-26.56 %
5 yr average Debt to Equity	0.71	0.9	-13.68
5yr CAGR Net Profit	23.51 %	50.43 %	-14.97 %
5yr Average Return on Assets	-10.1 %	5.01 %	-10.44 %
Shareholdings
Promoter Holding	59.25 %	67.47 %	7.77 %
Share Pledged by Promoters	0.0	0.0	14.8 %
Change in Promoter Holding (3 Yrs)	0.0	0.0	-13.19 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bharat Immunological	JFL Life Sciences	Vivimed Labs
Product Wise Break-Up	Product Wise Break-Up Oral Polio Vaccine 100.0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Pharmaceutical Products 0 Pharma 0 Speciality Chemicals 0	Product Wise Break-Up Pharmaceuticals 100.0 BIBSANIT 0 Oral Polio Vaccine 0 Pharma 0 Speciality Chemicals 0 BIB VIT 0 Zinc Tablets 0	Product Wise Break-Up Pharmaceutical Products 0 BIBSANIT 0 Oral Polio Vaccine 0 Pharmaceutical 100.0 Speciality Chemicals 0 BIB VIT 0 Zinc Tablets 0
Asset Break-Up	Asset Break-Up Oral Polio Vaccine 94.18 Zinc Tablets 0.04 BIB sweets Tablets 0 Pharma 0 Specialty Chemicals 0 Others 5.78	-	Asset Break-Up Oral Polio Vaccine 0 Specialty Chemicals 8.71 Pharma 91.29 BIB sweets Tablets 0 Zinc Tablets 0